The future of metabolomics in ELIXIR

← Back to publications

Published: 2017-09-10

Formatted citation

van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn W, Ebbels T, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia J, Jimenez R, Jourdan F, Kale N, Klapa M, Kohlbacher O, Koort K, Kultima K, Le Corguill G, Moschonas N, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek R, Sansone S, Satagopam V, Schober D, Shimmo R, Spicer R, Spjuth O, Thevenot E, Viant M, Weber R, Willighagen E, Zanetti G, and Steinbeck C. The future of metabolomics in ELIXIR.
F1000Research. 6(ELIXIR), 1649 (2017). DOI: 10.12688/f1000research.12342.2


Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.